English
Eli Lilly (LLY) · 2026-10-26 · Daily technical & news analysis
Eli Lilly (LLY) Technical Analysis — Chart, Levels & News
LLY Daily Market Briefing and News-Sentiment Read — October 26, 2026
Published Oct 27, 2026 ET · Updated Oct 27, 2026 ET · Stocks & ETFs
Information only. This page covers charts, levels, and news for context, not financial or trading advice.
Automated draft. Levels and signals are rules-based and use completed bars.
S&P 500 context: SPY +0.69% on 2026-10-26; this ticker +0.45% in the same completed session.
At a glance
Eli Lilly is above its 20-day (1,209.66), 50-day (1,188.58), and 200-day (1,085.91) averages. The trend reads up.
A typical day has moved about +3.16%% recently.
Support below: 1,251.25 | 1,230.66 | 1,209.66
Resistance above: Not enough completed bars for reliable levels.
What changed since the last close
No major technical change since the previous close.
Based on the completed 2026-10-26 session
More Healthcare tickers ETF coverage
Signal — short-term technical (daily chart)
On the short-term daily chart horizon, the technical bias is neutral to slightly bearish due to bearish momentum, though overall trend conditions retain an uptrend bias. No candlestick pattern was detected on the latest completed bar to provide timing context. The short-term daily technical stance remains cautious while moving averages maintain the broader structure.
News, Macro & Industry Context
The medium-term narrative tone is bullish, supported by positive fundamental updates and robust sector attention. Eli Lilly is highlighted in upcoming earnings charts and faces intense weight-loss market competition while approaching its next earnings report on October 29. Bernstein recently raised its price target on Eli Lilly to $1,450 from $1,385 citing a strong revenue outlook, and the company declared a fourth-quarter dividend of $1.73 per share. Broader healthcare and aging-population plays continue to attract non-AI investment interest.
Sector and macro background reflect a challenging broader market environment characterized by sideways consolidation, rotation, and high volatility. Bond market stresses, shifting interest rate expectations ahead of the FOMC meeting, and safe-haven flows into the US dollar create a complex macroeconomic backdrop.
Catalysts
Upcoming catalysts include Eli Lilly's earnings report scheduled for October 29, concurrent competitor updates in the obesity and weight-loss space, and broader macroeconomic data releases including upcoming Federal Reserve rate decisions.
Levels & Risk
Support is identified across the Fair Value Gap zones spanning 1259.75 to 1261.08, 1216.71 to 1251.25, 1193.30 to 1230.66, 1131.44 to 1131.59, and 1093.28 to 1131.03, alongside the Volume Area Low at 1011.38. Resistance is marked by the Volume Area High at 1231.84. Invalidation of the current short-term bullish trend bias occurs on a decisive break below moving average supports. Risk is managed by recognizing deeply overbought momentum conditions and potential earnings volatility.
Technical Breakdown
- WaveTrend: bearish momentum with fast below slow, deeply overbought in the fade zone.
- SMI: bearish, trading below signal line in mid-range.
- Trend: price remains above EMA20 indicating an uptrend bias, with EMA5 above EMA13 showing short-term bullish alignment.
- Triggers: Pickers sell column.
- Candlestick pattern: none detected on the latest completed bar.
- Higher timeframe: no higher-timeframe extreme.
2026-10-26 Daily brief
LLY is covered in the 2026-10-26 Daily brief. Read the 2026-10-26 brief.
Learn the chart
Start with the question you have, not a trading strategy. Each guide explains one part of a ticker page in plain language.
Educational technical analysis. Not financial advice. Market data may be delayed or incomplete.